Suppr超能文献

某三级甲等教学医院内科门诊处方药物中潜在不良药物相互作用的研究

A study of potential adverse drug-drug interactions among prescribed drugs in medicine outpatient department of a tertiary care teaching hospital.

作者信息

Patel Pankti S, Rana Devang A, Suthar Jalpa V, Malhotra Supriya D, Patel Varsha J

机构信息

Department of Pharmacology, Charotar University of Science and Technology, Changa, Gujarat, India.

Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India.

出版信息

J Basic Clin Pharm. 2014 Mar;5(2):44-8. doi: 10.4103/0976-0105.134983.

Abstract

OBJECTIVE

To evaluate prevalence, types, and severity of potential adverse drug-drug interaction in medicine out-patient department.

MATERIALS AND METHODS

A single-point, prospective, and observational study was carried out in medicine OPD. Study began after obtaining approval Institutional Ethics Committee. Data were collected and potential drug-drug interactions (pDDIs) were identified using medscape drug interaction checker and were analyzed.

RESULT

A total of 350 prescriptions with mean age 52.45 ± 14.49 years were collected over a period of 5 months. A total of 2066 pDDIs were recorded with mean of 5.90 ± 6.0. The prevalence of pDDI was 83.42%. Aspirin was most frequently prescribed drug in 185 (10.15%) out of total of 1821 drugs It was also the most frequent drug implicated in pDDI i.e. in 48.16%. The most common pDDI identified was metoprolol with aspirin in 126 (6.09%). Mechanism of interactions was pharmacokinetic in 553 (26.76%), pharmacodynamic in 1424 (68.92%) and 89 (4.30%) having an unknown mechanism. Out of all interactions, 76 (3.67%) were serious, 1516 (73.37%) significant, and 474 (22.94%) were minor interaction. Age of the patients (r = 0.327, P = 0.0001) and number of drugs prescribed (r = 0.714, P = 0.0001) are significantly correlated with drug interactions.

CONCLUSION

Aspirin being the most common drug interacting. The use of electronic decision support tools, continuing education and vigilance on the part of prescribers toward drug selection may decrease the problem of pDDIs.

摘要

目的

评估门诊潜在药物相互作用的发生率、类型及严重程度。

材料与方法

在门诊内科开展单点、前瞻性观察性研究。经机构伦理委员会批准后开始研究。收集数据并使用Medscape药物相互作用检查器识别潜在药物相互作用(pDDIs)并进行分析。

结果

在5个月的时间里共收集了350份处方,患者平均年龄为52.45±14.49岁。共记录到2066次pDDIs,平均为5.90±6.0。pDDI的发生率为83.42%。阿司匹林是1821种药物中最常被处方的药物,在185例(10.15%)中出现。它也是pDDI中最常涉及的药物,即48.16%。最常见的pDDI是美托洛尔与阿司匹林,共126例(6.09%)。相互作用机制中,药代动力学占553例(26.76%),药效学占1424例(68.92%),89例(4.30%)机制不明。在所有相互作用中,76例(3.67%)为严重相互作用,1516例(73.37%)为显著相互作用,474例(22.94%)为轻微相互作用。患者年龄(r = 0.327,P = 0.0001)和处方药物数量(r = 0.714,P = 0.0001)与药物相互作用显著相关。

结论

阿司匹林是最常见的相互作用药物。使用电子决策支持工具、开展继续教育以及开处方者在药物选择方面保持警惕,可能会减少pDDIs问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f132/4074695/0d0b907fda5e/JBCP-5-44-g002.jpg

相似文献

2
Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
Int J Clin Pharm. 2013 Jun;35(3):455-62. doi: 10.1007/s11096-013-9764-1. Epub 2013 Mar 13.
4
Preventing potential drug-drug interactions through alerting decision support systems: A clinical context based methodology.
Int J Med Inform. 2019 Jul;127:18-26. doi: 10.1016/j.ijmedinf.2019.04.006. Epub 2019 Apr 13.
5
Potential drug-drug interactions in outpatients with depression of a psychiatry department.
Saudi Pharm J. 2023 Feb;31(2):207-213. doi: 10.1016/j.jsps.2022.12.004. Epub 2022 Dec 15.
6
Clinical Pertinence and Determinants of Potential Drug-Drug Interactions in Chronic Kidney Disease Patients: A Cross-sectional Study.
J Pharm Technol. 2024 Jun;40(3):142-151. doi: 10.1177/87551225241241977. Epub 2024 Apr 3.
7
Potential Drug-Drug Interactions among Patients prescriptions collected from Medicine Out-patient Setting.
Pak J Med Sci. 2018 Jan-Feb;34(1):144-148. doi: 10.12669/pjms.341.13986.
8
A Prospective Analysis of Drug Interactions in Patients of Intensive Cardiac Care Unit.
J Clin Diagn Res. 2017 Mar;11(3):FC01-FC04. doi: 10.7860/JCDR/2017/23638.9403. Epub 2017 Mar 1.
9
Evaluation of potential drug - drug interactions in general medicine ward of teaching hospital in southern India.
J Clin Diagn Res. 2015 Feb;9(2):FC10-3. doi: 10.7860/JCDR/2015/11264.5608. Epub 2015 Feb 1.
10
Study of drug-Drug interactions among the hypertensive patients in a tertiary care teaching hospital.
Perspect Clin Res. 2018 Jan-Mar;9(1):9-14. doi: 10.4103/picr.PICR_145_16.

引用本文的文献

1
Real-World Evaluation of the Interaction Between Rifampicin and Warfarin: A Retrospective Observational Study.
Adv Pharmacol Pharm Sci. 2025 Jul 29;2025:5607280. doi: 10.1155/adpp/5607280. eCollection 2025.
2
Risk Factors and Patterns of Drug-Drug Interactions in Two Categories of Level-3 Hospitals in Dhaka: A Cross-Sectional Study.
Health Sci Rep. 2025 Jan 14;8(1):e70355. doi: 10.1002/hsr2.70355. eCollection 2025 Jan.
3
Warfarin and Polypharmacy Challenges in Sudan: Drug Interactions in Patient Cohort.
Integr Pharm Res Pract. 2024 Jun 26;13:81-89. doi: 10.2147/IPRP.S458827. eCollection 2024.
5
Prevalence of Potential Drug-Drug Interactions Among Hypertensive Pregnant Women Admitted to a Tertiary Care Hospital.
Cureus. 2023 Mar 17;15(3):e36306. doi: 10.7759/cureus.36306. eCollection 2023 Mar.
9
A Prospective Study of Medication Surveillance of a Pediatric Tertiary Care Hospital in Lahore, Pakistan.
Pediatr Rep. 2022 Jun 15;14(2):312-319. doi: 10.3390/pediatric14020038.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验